Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer’s disease

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer’s disease

Alzheimer’s disease (AD) is the most common form of dementia. AD is a progressive neurodegenerative disorder characterized by cognitive dysfunction, including learning and memory deficits, and behavioral changes. Neuropathology hallmarks of AD such as amyloid beta (Aβ) plaques and neurofibrillary ta...

Full description

Bibliographic Details
Main Authors: Matin Ramezani, Malika Fernando, Shaun Eslick, Prita R. Asih, Sina Shadfar, Ekanayaka M. S. Bandara, Heidi Hillebrandt, Silochna Meghwar, Maryam Shahriari, Pratishtha Chatterjee, Rohith Thota, Cintia B. Dias, Manohar L. Garg, Ralph N. Martins
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Neuroscience
Subjects:
ketogenic intervention
disease-modifying therapy
Alzheimer’s disease
circulating biomarkers
metabolic interaction
ketogenesis
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1297984/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2023.1297984/full

Similar Items